New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development? Michael BerryBrijesh V. PatelStephen J. Brett Current Opinion 10 February 2017 Pages: 353 - 361
Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview Pieter HindryckxGregor NovakBrian G. Feagan Review Article 23 February 2017 Pages: 363 - 377
Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview Pieter HindryckxGregor NovakBrian G. Feagan Erratum 01 March 2017 Pages: 379 - 379
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression Marc S. LenerBashkim KadriuCarlos A. Zarate Jr Review Article 14 February 2017 Pages: 381 - 401
Abuse and Misuse of Pregabalin and Gabapentin Kirk E. EvoyMegan D. MorrisonStephen R. Saklad Systematic Review 01 February 2017 Pages: 403 - 426
Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence Joshua J. GagneJennifer M. PolinskiAaron S. Kesselheim Original Research Article 08 February 2017 Pages: 427 - 433
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma Lesley J. Scott Adis Drug Evaluation 11 February 2017 Pages: 435 - 445
Daclizumab: A Review in Relapsing Multiple Sclerosis Matt Shirley Adis Drug Evaluation 17 February 2017 Pages: 447 - 458
Apremilast: A Review in Psoriasis and Psoriatic Arthritis Gillian M. Keating Adis Drug Evaluation 18 February 2017 Pages: 459 - 472
Nusinersen: First Global Approval Sheridan M. Hoy AdisInsight Report 22 February 2017 Pages: 473 - 479
